跳至主要内容
临床试验/CTRI/2023/12/060492
CTRI/2023/12/060492尚未招募3 期

Comparison of clinical outcomes and patient satisfaction of two Hydrophobic EDOF Toric intraocular lenses following bilateral implantation. - NI

Biotech Vision Care Pvt Ltd Ahmedabad India0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Cataractous lens changes as demonstrated by best corrected
  • visual acuity of 20/40 or worse either with or without a glare
  • source present (e.g., Brightness Acuity Tester) or with significant
  • cataract-related visual symptoms.
  • 2. Best corrected visual acuity to be better than 20/30 after cataract
  • removal and IOL implantation as estimated by potential acuity
  • meter (PAM) or surgeon estimation
  • 3. Clear intraocular media other than cataract.
  • 4. Given written informed consent by subject.
  • 5. Subjects are willing and able to comply with schedule for follow up visits.
  • 6. Subjects should be 22 years or older.

排除标准

  • 1. Systemic disease that could increase the operative risk or
  • confound the outcome.
  • 2. Systemic medications that may confound the outcome or increase
  • the risk to the subject in the opinion of the investigator
  • (tamsulosin hydrochloride (Flomax) or other medications with
  • similar side effects (floppy iris syndrome)).
  • 3. Ocular condition that may predispose for future complications.
  • 4. Previous intraocular or corneal surgery that might confound the
  • outcome of the investigation or increase the risk to the subject.

研究者

发起方
Biotech Vision Care Pvt Ltd Ahmedabad India

相似试验